Glucosamine vs. MSM for Dog Joint Pain: What the Evidence Actually Supports

By Justin Shmalberg, DVM, CVA, ACVN, ACVSMR

Comparisons · August 14, 2026 · 6 min read

Glucosamine and MSM work through different pathways, and the evidence for each is thinner than most labels suggest.

A twelve-year-old beagle named Cooper stopped jumping onto the porch step sometime that winter, and his owner couldn’t say exactly when — just that one Tuesday she noticed him pausing at the bottom, front paws planted, deciding whether the effort was worth it. She’d already been giving him a glucosamine chew for eight months because a neighbor swore by it. When she asked me in the exam room whether she should switch to something with MSM in it, I gave her the same answer I give most owners: it depends on what you’re actually trying to fix, and neither ingredient is going to do what the marketing implies on its own.

That question — glucosamine or MSM, or both — comes up constantly, and it deserves a straighter answer than most product pages give it.

What glucosamine is actually doing in the joint

Glucosamine is an amino sugar that’s a building block for glycosaminoglycans, the molecules that make up cartilage matrix. The logic behind supplementing it is straightforward: give the joint more raw material and, theoretically, support cartilage maintenance. The clinical evidence is where things get less tidy. A Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis: PubMed trial found dogs on glucosamine and chondroitin sulfate showed statistically significant improvements in pain, weight-bearing, and overall severity scores by day 70 — a real signal, but a slow one, with response lagging behind NSAID treatment in the same study. A separate prospective clinical trial in PMC comparing glucosamine/chondroitin against marine-based fatty acid compounds and carprofen for hip osteoarthritis found the glucosamine group’s improvement in peak vertical force was not significantly different from placebo at four weeks, and only landed between placebo and the more effective treatments by six weeks. A frequently cited review is blunter still: a What is the evidence? There is only very weak clinical trial evidence to support the use of glucosamine and chondroitin supplements for osteoarthritis in dogs: PubMed evidence review concluded there is only very weak clinical trial evidence supporting glucosamine and chondroitin for canine osteoarthritis.

I don’t read that as “glucosamine doesn’t work.” I read it as “glucosamine is a modest, slow-onset structure/function ingredient, not a substitute for a diagnosis or a pain-management plan.” That distinction matters more than most owners realize.

Where MSM fits, and why the evidence trail is thinner

MSM — methylsulfonylmethane — is an organosulfur compound, and sulfur is a genuine building block for connective tissue: cartilage, tendons, and ligaments all depend on it. But the research base in dogs specifically is sparse. Most of what gets cited for MSM in pet products is extrapolated from human and equine studies, not canine trials. The most substantial human data point — 6 grams daily for 12 weeks in people with knee osteoarthritis — showed a meaningful drop in pain and swelling, and the effect was larger when MSM was combined with glucosamine rather than used alone, a detail worth remembering before you assume the two are competitors rather than complements.

I’ve watched this play out with a nine-year-old Labrador named Sadie, whose owner had her on a glucosamine-only chew for over a year with no obvious change in her stiffness after rest. Sadie was 68 pounds, mostly sedentary during the workday, and her stiffness was worst in the first ten minutes after getting up from the tile kitchen floor — a classic morning-stiffness pattern. We didn’t abandon glucosamine, because there was nothing wrong with it; we added an MSM-containing product and reassessed at six weeks, which is roughly the window most of this evidence suggests you need before judging whether anything is helping. Her owner reported Sadie was making it up the porch steps in one motion again rather than pausing halfway, which is exactly the kind of change worth tracking — one dog, one household, not a study result, but it’s the sort of pattern that lines up with what the mixed human combination data would predict.

What actually separates the two, side by side

• Mechanism: Glucosamine supplies cartilage-matrix building blocks; MSM supplies sulfur for connective tissue and is more commonly framed around reducing inflammatory discomfort.
• Evidence strength in dogs: Glucosamine has more canine-specific trial data, and it’s mixed-to-weak. MSM has almost no dog-specific trials; most support is extrapolated from human and equine research.
• Onset: Both are slow. Expect 4–8 weeks before judging effect, not days.
• Combination data: The strongest human signal for MSM specifically comes from combining it with glucosamine, not using it alone.
• Format matters as much as ingredient: how well the base absorbs and how consistently the dog will actually eat it can matter more than which of these two ingredients is on the label — see our breakdown of chew vs. powder vs. liquid supplements for what changes.

What I actually tell owners in the exam room

Here’s the honest version: neither ingredient is a cure, and neither is snake oil. If your dog has mild, age-related stiffness and you want a structure/function supplement to sit alongside diet and exercise, a combination product with both glucosamine and MSM has the best evidence footing of the options discussed here — not because either ingredient is individually powerful, but because the one dataset showing a meaningful effect used them together. If your dog’s stiffness is worsening, asymmetric, or paired with reluctance to bear weight on one limb, that’s not a supplement question anymore. That’s an exam and probably imaging.

Before reaching for any joint product, it’s worth ruling out that what you’re seeing is ordinary aging rather than osteoarthritis — the two look similar from the couch. Our guide on arthritis versus normal aging stiffness walks through the distinguishing signs. And if glucosamine and MSM haven’t moved the needle after a full trial period, there are other evidence-backed options worth discussing with your vet, covered in our piece on natural alternatives to glucosamine.

I’ll admit I’ve become more conservative about this category over the years, not less.

I’ve also come to trust NASC membership as a baseline quality filter, since it at least signals the manufacturer follows some testing and reporting standard — though it says nothing about whether the specific formula and dose on the label actually match what got tested in a trial. Reading the label for actual milligram amounts per dose, not just “contains glucosamine,” is a habit worth building before you buy anything in this aisle. For a sense of how our panel actually weighs dose, testing, and evidence before handing down a verdict, see how our reviewing vets score dog supplements.

The verdict

Glucosamine has more dog-specific data than MSM, but that data is modest — significant in some trials, indistinguishable from placebo in others. MSM’s evidence in dogs is thin on its own, but the strongest available combination data suggests it may add something when paired with glucosamine rather than used solo. For a dog with mild-to-moderate age-related stiffness and no red-flag signs, a combined glucosamine/MSM product with transparent dosing and NASC membership is a reasonable, low-risk structure/function choice — give it a full 6-to-8-week trial before deciding whether to keep it, switch formats, or move on to a vet exam.